HemaSure, Novo Nordisk deal

HMSR acquired Novo Nordisk's Plasma Products Unit for up to $22.8 million (see BioCentury, Feb. 5). Payment includes $1.8 million for raw materials, payable at HMSR's discretion in stock or cash. If HMSR elects to issue stock, the price is fixed at $18.50. ...